Replicative RNA reporter systems

• US 5,364,760 A
• Filed: 09/22/1992
• Issued: 11/15/1994
• Est. Priority Date: 04/16/1986
• Status: Expired due to Fees

• Current Assignee: Trustees Of Columbia University In The City Of New York (Columbia University), Salk Institute for Biological Studies
• Original Assignee: Trustees Of Columbia University In The City Of New York (Columbia University), Salk Institute for Biological Studies
• Inventors: Lizardi, Paul, Chu, Barbara, Kramer, Fred R., Orgel, Leslie E.
• Primary Examiner(s): BICKEL, MINDY B
• Application Number:
  US07/949,766
• Time in Patent Office: 784 Days
• Field of Search: 435/6, 435/7.1, 435/91.2, 435/188, 435/810, 436/501, 436/547, 436/827, 935/78, 530/387, 536/23.1
• US Class Current: 435/6.13
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/6867 Replicase-based amplification, e.g. using Q-beta replicase
• CPC Class Codes: C12Q 2521/119 RNA polymerase
• CPC Class Codes: C12Q 2525/121 incorporating both deoxyribonucleotides and ribonucleotides
• CPC Class Codes: C12Q 2531/149 Replicase based amplification, e.g. Q beta replicase
• CPC Class Codes: C12Q 2563/179 the label being a nucleic acid
• CPC Class Codes: G01N 33/532 Production of labelled immunochemicals
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 436/827 Lectins

Abstract

Highly sensitive methods for assaying for biopolymers, such as by immunoassay or nucleic acid probe hybridization assay, and compositions for carrying out the methods, are provided. The methods employ as reporter group a RNA capable of being autocatalytically replicated by an RNA-dependent RNA polymerase, such as the replicase of bacteriophage Qβ. The high sensitivity of the assay methods is due to the rapid, exponential increase in concentration of such a replicative RNA, associated specifically with biopolymer analyte, that can be achieved by autocatalytic RNA replication.

Claims

1. A method of determining the presence of a biopolymer analyte in a sample, which method comprises

(i) exposing the sample to an affinity molecule for said analyte under conditions whereby binding occurs between the affinity molecule and the analyte;

(ii) if said affinity molecule is not itself a replicative RNA, joining, either before or after step (i), a replicative RNA to the affinity molecule employed in step (i);

(iii) employing a RNA-dependent RNA polymerase to catalyze replication of replicative RNA that is or had been joined to affinity molecule bound to analyte or that is affinity molecule that had been bound to analyte; and

(iv) detecting RNA made by the reaction of step (iii).

2. A method according to claim 1 wherein the analyte is a nucleic acid, the affinity molecule is a replicative RNA which includes a segment with a sequence of about 20 to about 4000 bases complementary to the sequence of a segment of the analyte, and the replication of said replicative RNA is after dissociation thereof from analyte.

3. A method according to claim 1 wherein the joining of replicative RNA to affinity molecule is effected through a first linking moiety, joined to the replicative RNA without eliminating the replicability thereof by a RNA-dependent RNA polymerase, and a second linking moiety, joined to the affinity molecule without eliminating the specificity of binding between affinity molecule and analyte, said first and second linking moieties either being covalently joined to each other or being a specific binding pair.

4. A method according to claim 1 wherein the joining of replicative RNA to affinity molecule is effected by hybridization of replicative RNA to a segment of nucleic acid at least 10 bases in length joined to or included in affinity molecule.

5. A method according to claim 2 wherein the replication of replicative RNA is carried out with a radioactively labeled ribonucleoside-5'"'"'-triphosphate and the resulting replicated RNA is radioactively labeled.

6. A method according to claim 3 wherein the replication of replicative RNA is carried out with a radioactively labeled ribonucleoside-5'"'"'-triphosphate and the resulting replicated RNA is radioactively labeled.

7. A method according to claim 6 wherein, prior to exposing the affinity molecule to the sample, the first linking moiety and second linking moiety are covalently joined to each other by a disulphide moiety.

8. A method according to claim 7 wherein the first linking moiety is of formula --O--PO₂ --NH--(CH₂)_n --S--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide of the replicative RNA and n is 2 to 8, and the second linking moiety is of formula --O--PO₂ --NH--(CH₂)_m --S--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide of a nucleic acid affinity molecule and m is the same as or different from n and is 2 to 8.

9. A method according to claim 6 wherein the affinity molecule is a nucleic acid with a segment of at least 1 purine residue, which segment is at the 3'"'"'-terminus of the affinity molecule and outside the analyte-binding segment of the affinity molecule, said 3'"'"'-terminus of the affinity molecule bonded through a phosphodiester to the 5'"'"'-carbon of the 5'"'"'-nucleotide of the replicative RNA.

10. A method according to claim 6 wherein affinity molecule and replicative RNA are combined in a smart probe, wherein the affinity molecule is a nucleic acid which comprises a sequence which is capable of hybridizing with a complementary sequence of the replicative RNA and wherein the affinity molecule portion and the replicative RNA portion are associated so that the replicative RNA portion is inactive for replication by the RNA-dependent RNA polymerase unless the affinity molecule portion is associated with its analyte.

11. A method according to claim 6 wherein the first and second linking moieties are a specific binding pair.

12. A method according to claim 11 wherein one of the first and second linking moieties is biotinyl and the other is avidin joined to affinity molecule or replicative RNA through complexing to biotinyl.

13. A method according to claim 12 wherein a biotinyl moiety is linked to the 5'"'"'-nucleotide of the replicative RNA by a spacer arm of formula --O--OP₂ --NH--(CH₂)_p (SS)_q (CH₂)_r NH--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide, wherein p and r are the same or different and are each 2 to 8, and wherein q is 0 or 1.

14. A method according to claim 13 wherein the affinity molecule is a biotinylated antibody and avidin is complexed to the biotinyl joined to replicative RNA.

15. A method according to claim 13 wherein the affinity molecule is a biotinylated lectin and avidin is complexed to the biotinyl joined to replicative RNA.

16. A method according to claim 13 wherein the affinity molecule is a nucleic acid biotinylated photochemically with photobiotin, enzymatically with dUTP or UTP that is linked to biotinyl through C-5 of the uracil moiety or dATP that is linked to biotinyl through C-6 or C-8 of the adenine moiety, or chemically at the 5'"'"'-carbon of the 5'"'"'-nucleotide through a spacer arm of formula --O--PO₂ --NH--(CH₂)_s (SS)_t (CH₂)_u NH--, wherein the phosphocamidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide, wherein s and u are the same or different and are each 2 to 8, and wherein t is 0 to 1;

and wherein avidin is complexed to biotinyl joined to replicative RNA.

17. A method according to claim 16 wherein the affinity molecule is biotinylated at the 5'"'"'-carbon of the 5'"'"'-nucleotide.

18. A method according to claim 7 wherein, after binding of affinity molecule, joined to replicative DNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide covalently joining the first and second linking moieties.

19. A method according to claim 8 wherein, after binding of affinity molecule, joined to replicative DNA, to analyte, and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide covalently joining the first and second linking moieties.

20. A method according to claim 9 wherein, after binding of affinity molecule, joined to replicative DNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by acid depurination followed by β

-elimination to sever the phosphodiester bond.

21. A method according to claim 10 wherein, after binding of affinity molecule, joined to replicative DNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide covalently joining the first and second linking moieties.

22. A method according to claim 13 wherein q in the spacer group is 1;

and wherein, after binding of affinity molecule, joined to replicative RNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide of the spacer arm joining replicative RNA to biotinyl.

23. A method according to claim 14 wherein q in the spacer group is 1;

and wherein, after binding of affinity molecule, joined to replicative RNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide of the spacer arm joining replicative RNA to biotinyl.

24. A method according to claim 15 wherein q in the spacer group is 1;

and wherein, after binding of affinity molecule, joined to replicative RNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide of the spacer arm joining replicative RNA to biotinyl.

25. A method according to claim 17 wherein q in the spacer group is 1;

and wherein, after binding of affinity molecule, joined to replicative RNA, to analyte and prior to replication of replicative RNA, replicative RNA is severed from affinity molecule by reduction of the disulfide of the spacer arm joining replicative RNA to biotinyl.

26. A method according to claim 4 wherein the affinity molecule is a nucleic acid.

51. A method according to claim 2 wherein, prior to catalyzing replication of replicative RNA in step (iii), replicative RNA bound to analyte or joined to affinity molecule bound to analyte is separated from replicative RNA not bound to analyte or joined to affinity molecule bound to analyte.

52. A method according to claim 3 wherein, prior to catalyzing replication of replicative RNA in step (iii), replicative RNA bound to analyte or joined to affinity molecule bound to analyte is separated from replicative RNA not bound to analyte or joined to affinity molecule bound to analyte.

53. A method according to claim 4 wherein, prior to catalyzing replication of replicative RNA in step (iii), replicative RNA bound to analyte or joined to affinity molecule bound to analyte is separated from replicative RNA not bound to analyte or joined to affinity molecule bound to analyte.

27. An affinity molecule-replicative RNA hybrid wherein the affinity molecule is joined to a replicative RNA through a first linking moiety, joined to the replicative RNA without eliminating the replicability of the replicative RNA by a RNA-dependent RNA polymerase, and a second linking moiety, joined to the affinity molecule without eliminating the specificity of binding between affinity molecule and its analyte, said first and second linking moieties being covalently joined to each other or being a specific binding pair.

28. An affinity molecule-replicative RNA hybrid, in accordance with claim 27, wherein the second linking moiety and first linking moiety are covalently joined to the affinity molecule and the replicative RNA, respectively, and are covalently joined to each other by a disulphide moiety.

29. An affinity molecule joined to a replicative RNA, in accordance with claim 28, wherein the affinity molecule is a nucleic acid, the first linking moiety is of formula --O--PO₂ --NH--(CH₂)_n --S--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide of the replicative RNA and n is 2 to 8, and the second linking moiety is of formula --O--PO₂ --NH--(CH₂)_m --S--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide of the affinity molecule, and m is the same as or different from n and is 2 to 8.

30. An affinity molecule joined to a replicative RNA, in accordance with claim 27, wherein the affinity molecule is a nucleic acid with a segment of at least 1 purine residue which is at the 3'"'"'-terminus of the affinity molecule and outside the segment of affinity molecule with sequence complementary to that of target segment of analyte, said 3'"'"'-terminus of the affinity molecule bonded through a phosphodiester to the 5'"'"'-carbon of the 5'"'"'-nucleotide of said replicative RNA.

31. An affinity molecule joined to a replicative RNA, in accordance with claim 27, wherein the first and second linking moieties are a specific binding pair.

32. An affinity molecule joined to a replicative RNA, in accordance with claim 31, wherein one of the linking moieties is biotinyl and other avidin, joined to affinity molecule or replicative RNA through complexing to biotinyl.

33. An affinity molecule joined with a replicative RNA, in accordance with claim 32, wherein a biotinyl moiety is linked to the 5'"'"'-nucleotide of the replicative RNA by a spacer arm of formula --O--PO₂ --NH--(CH₂)_p (SS)_q (CH₂)_r NH--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide, wherein p and r are the same or different and are each 2 to 8, and wherein q is 0 or 1.

34. An affinity molecule joined with a replicative RNA, in accordance with claim 33, wherein the affinity molecule is a biotinylated antibody.

35. An affinity molecule joined with a replicative RNA, in accordance with claim 33, wherein the affinity molecule is a biotinylated lectin.

36. An affinity molecule joined with a replicative RNA, in accordance with claim 33, wherein the affinity molecule is a nucleic acid biotinylated photochemically with photobiotin, enzymatically with dUTP or UTP, that is linked to biotinyl through C-5 of the uracil moiety, or dATP, that is linked to biotinyl through C-6 or C-8 of the adenine moiety, or chemically at the 5'"'"'-carbon of the 5'"'"'-nucleotide through a spacer arm of formula --O--PO₂ --NH--(CH₂)_s (SS)_t (CH₂)_u NH--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide, wherein s and u are the same or different and are each 2 to 8, and wherein t is 0 or 1.

37. An affinity molecule joined to a replicative RNA, in accordance with claim 36, wherein the affinity molecule is biotinylated at the 5'"'"'-carbon of the 5'"'"'-nucleotide.

38. A replicative RNA joined to a linking moiety, without eliminating the replicability in vitro of the replicative RNA by an RNA-dependent RNA polymerase, said linking moiety being capable of effecting a linkage between the replicative RNA and an affinity molecule through covalent linkage to, or being one member of a specific binding pair with, a linking moiety which is joined to the affinity molecule.

39. A replicative RNA in accordance with claim 38 wherein the linking moiety to which the replicative RNA is joined is sulfur, biotinyl, or avidin which is joined through a complex with biotinyl which, in turn, is joined to the replicative RNA.

40. A replicative RNA in accordance with claim 39 wherein the linking moiety is biotinyl or avidin, and, with either, biotinyl is linked to the 5'"'"'-nucleotide of the replicative RNA by a spacer group of formula --O--PO₂ --NH--(CH₂)_p (SS)_q (CH₂)_r NH--, wherein the phosphoramidate moiety is bonded to the 5'"'"'-carbon of the 5'"'"'-nucleotide, wherein p and r are the same or different and are each 2 to 8, and wherein q is 0 or 1.

41. A replicative RNA in accordance with claim 39 wherein the linking moiety is sulfur and is joined to the 5'"'"'-nucleotide of replicative RNA by a spacer group of formula --O(PO₂)NH(CH₂)_p --, wherein the phosphoramidate group is joined to the 5'"'"'-carbon of the 5'"'"'-nucleotide and wherein p is 2 to 8.

42. A smart probe comprising a replicative RNA covalently joined to a nucleic acid affinity molecule, wherein the affinity molecule is a nucleic acid which comprises a sequence which is capable of hybridizing with a complementary sequence of the replicative RNA and wherein the affinity molecule portion and the replicative RNA portion are associated so that the replicative RNA portion is inactive for replication by the RNA-dependent RNA polymerase unless the affinity molecule portion is associated with its analyte.

43. A smart probe according to claim 42 wherein the replicative RNA is a template for replication by Qβ

replicase and the 5'"'"'-carbon of the 5'"'"'-nucleotide of the replicative RNA and the 5'"'"'-carbon of the 5'"'"'-nucleotide of the affinity molecule are joined by a moiety of formula --O(PO₂)NH(CH₂)_y SS(CH₂)_z NH(PO₂)O--, wherein y and z are the same or different and are each from 2 to 8.

44. A smart probe according to claim 43 wherein the affinity molecule has both a 5'"'"'-clamp segment and a 3'"'"'-clamp segment.

45. A smart probe according to claim 43 wherein the replicative RNA is a recombinant replicative RNA with a segment with a sequence complementary to that of a segment at the 3'"'"'-end of the affinity molecule.

46. An affinity molecule-replicative RNA hybrid wherein the replicative RNA is a template for replication in vitro by Qβ

replicase and the affinity molecule is joined to the replicative RNA by hybridization of the replicative RNA to a first segment of nucleic acid at least 10 bases in length joined to or included in the affinity molecule, provided that, if the affinity molecule is a nucleic acid, the affinity molecule comprises a second segment which is not hybridized to the replicative RNA in the affinity molecule-replicative RNA hybrid.

47. An affinity molecule-replicative RNA hybrid according to claim 46 wherein the affinity molecule is a protein.

48. An affinity molecule-replicative RNA hybrid according to claim 47 wherein the replicative RNA is a template for replication in vitro by Qβ

replicase.

49. An affinity molecule-replicative RNA hybrid according to claim 46 wherein the affinity molecule is a nucleic acid.

50. An affinity molecule-replicative RNA hybrid according to claim 49 wherein the replicative RNA is a template for replication in vitro by Qβ

replicase.